{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "18438177",
  "DateCompleted": {
    "Year": "2008",
    "Month": "07",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/MED.0b013e3282fc27eb"
    ],
    "Journal": {
      "ISSN": "1752-2978",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "3",
        "PubDate": {
          "Year": "2008",
          "Month": "Jun"
        }
      },
      "Title": "Current opinion in endocrinology, diabetes, and obesity",
      "ISOAbbreviation": "Curr Opin Endocrinol Diabetes Obes"
    },
    "ArticleTitle": "Testosterone and depression in men.",
    "Pagination": {
      "StartPage": "278",
      "EndPage": "283",
      "MedlinePgn": "278-83"
    },
    "Abstract": {
      "AbstractText": [
        "The purpose of the review is to update the current literature regarding the role, if any, that testosterone plays in depressive illness. We have considered the influences on depression of endogenous testosterone, that is, hypogonadism and depression; and exogenous testosterone, that is, as a potential antidepressant.",
        "Studies do not support a consistent relationship between testosterone level and mood. There may be vulnerable subpopulations in whom hypogonadism contributes to depression; and chronic depressive illness may lead to hypogonadism in some men. Results from multiple randomized, controlled clinical trials are conflicting. Most do not support testosterone as a broadly effective antidepressant, but it may be effective in carefully selected populations, such as hypogonadal men, antidepressant-resistant men, men with early onset depression, and/or HIV-infected men.",
        "There is little support for a pervasive influence of testosterone on mood."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chaim Sheba Medical Center, Tel Hashomer, Israel."
          }
        ],
        "LastName": "Amiaz",
        "ForeName": "Revital",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Seidman",
        "ForeName": "Stuart N",
        "Initials": "SN"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Curr Opin Endocrinol Diabetes Obes",
    "NlmUniqueID": "101308636",
    "ISSNLinking": "1752-296X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "3XMK78S47O",
      "NameOfSubstance": "Testosterone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Affect"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Hormone Replacement Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Hypogonadism"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "deficiency",
        "therapeutic use"
      ],
      "DescriptorName": "Testosterone"
    }
  ],
  "NumberOfReferences": "57"
}